NCT02185534View on ClinicalTrials.gov

Clopidogrel Bioequivalence Study in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Bioequivalence, AUC, Cmax, Pharmacokinetics
Interventions
DRUG

Clopidogrel

European clopidogrel tablets, 75 mg (test) versus Japanese clopidogrel tablets, 75 mg (reference); European clopidogrel tablets, 75 mg (test) versus US clopidogrel tablets, 75 mg (reference)

Trial Locations (1)

Unknown

Research Site, Berlin

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY